Trials / Unknown
UnknownNCT02815176
Angiographic Characteristics of CSC, PCV Patients and Thrombotic Bio-markers
Analysis of Plasminogen Activator Inhibitor-1 Level in Chronic Serous Chorioretinopathy and Polypoidal Choroidal Vasculopathy
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Thrombotic biomarkers and angiographic characteristics were compared among the de novo patients of central serous chorioretinopathy (CSC), polypoidal choroidal vasculopathy (PCV) and the control.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood sampling | Sampling the blood including DNA to investigate the thrombotic profile |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2017-06-01
- Completion
- 2017-06-01
- First posted
- 2016-06-28
- Last updated
- 2016-06-29
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02815176. Inclusion in this directory is not an endorsement.